User profiles for Giovana T. Torrezan
 | Giovana Tardin TorrezanPesquisadora, AC Camargo Cancer Center Verified email at accamargo.org.br Cited by 1022 |
[HTML][HTML] Recurrent somatic mutation in DROSHA induces microRNA profile changes in Wilms tumour
GT Torrezan, EN Ferreira, AM Nakahata… - Nature …, 2014 - nature.com
Wilms tumour (WT) is an embryonal kidney neoplasia for which very few driver genes have
been identified. Here we identify DROSHA mutations in 12% of WT samples (26/222) using …
been identified. Here we identify DROSHA mutations in 12% of WT samples (26/222) using …
[HTML][HTML] Hereditary breast and ovarian cancer: assessment of point mutations and copy number variations in Brazilian patients
…, BCG Lisboa, MCP Figueiredo, GT Torrezan… - BMC medical …, 2014 - Springer
Background Germ line mutations in BRCA1 and BRCA2 (BRCA1/2) and other susceptibility
genes have been identified as genetic causes of hereditary breast and ovarian cancer (…
genes have been identified as genetic causes of hereditary breast and ovarian cancer (…
Whole‐exome sequencing of non‐BRCA1/BRCA2 mutation carrier cases at high‐risk for hereditary breast/ovarian cancer
…, AE de Paula, HCR Galvão, GT Torrezan… - Human …, 2021 - Wiley Online Library
The current study aimed to identify new breast and/or ovarian cancer predisposition genes.
For that, whole‐exome sequencing (WES) was performed in the germline DNA of 52 non‐…
For that, whole‐exome sequencing (WES) was performed in the germline DNA of 52 non‐…
[HTML][HTML] Complex landscape of germline variants in Brazilian patients with hereditary and early onset breast cancer
GT Torrezan, FGSR de Almeida, MCP Figueiredo… - Frontiers in …, 2018 - frontiersin.org
Pathogenic variants in known breast cancer (BC) predisposing genes explain only about 30%
of Hereditary Breast Cancer (HBC) cases, whereas the underlying genetic factors for most …
of Hereditary Breast Cancer (HBC) cases, whereas the underlying genetic factors for most …
[HTML][HTML] High prevalence of EGFR mutations in lung adenocarcinomas from Brazilian patients harboring the TP53 p. R337H variant
…, MN Formiga, CAA de Paula, GT Torrezan… - Clinical Lung Cancer, 2020 - Elsevier
Lung cancer represents around 3.6% of all Li-Fraumeni syndrome–associated tumors. A high
prevalence of p. R337H germline mutation in the TP53 gene has been observed in Brazil …
prevalence of p. R337H germline mutation in the TP53 gene has been observed in Brazil …
[HTML][HTML] Breakpoint characterization of a novel large intragenic deletion of MUTYH detected in a MAP patient: Case report
GT Torrezan, FCC da Silva, ACV Krepischi… - BMC medical …, 2011 - Springer
Background MUTYH-associated polyposis (MAP) is a recessive, hereditary, colorectal
cancer-predisposing syndrome caused by biallelic mutations in the MUTYH gene. Most MUTYH …
cancer-predisposing syndrome caused by biallelic mutations in the MUTYH gene. Most MUTYH …
[HTML][HTML] Mutation detection in tumor-derived cell free DNA anticipates progression in a patient with metastatic colorectal cancer
Background: The observation of tumor-derived cell-free DNA (ctDNA) in plasma brought
new expectations to monitor treatment response in cancer patients. Case presentation: In an …
new expectations to monitor treatment response in cancer patients. Case presentation: In an …
[HTML][HTML] Colorectal cancer incidences in Lynch syndrome: a comparison of results from the prospective lynch syndrome database and the international mismatch …
…, WH Pavicic, P Kalfayan, GT Torrezan - Hereditary cancer in …, 2022 - Springer
Objective To compare colorectal cancer (CRC) incidences in carriers of pathogenic variants
of the MMR genes in the PLSD and IMRC cohorts, of which only the former included …
of the MMR genes in the PLSD and IMRC cohorts, of which only the former included …
[HTML][HTML] Mortality by age, gene and gender in carriers of pathogenic mismatch repair gene variants receiving surveillance for early cancer diagnosis and treatment: a …
…, W Pavicic, GT Torrezan, T Bassaneze… - …, 2023 - thelancet.com
Background The Prospective Lynch Syndrome Database (PLSD) collates information on
carriers of pathogenic or likely pathogenic MMR variants (path_MMR) who are receiving …
carriers of pathogenic or likely pathogenic MMR variants (path_MMR) who are receiving …
[HTML][HTML] Genetic landscape of male breast cancer
FAB Campos, E Rouleau, GT Torrezan, DM Carraro… - Cancers, 2021 - mdpi.com
Simple Summary Male breast cancer is a rare disease, representing around 0.5% of the
malignances in men. Although they receive the same treatment as women with breast cancer, …
malignances in men. Although they receive the same treatment as women with breast cancer, …